Luther King Capital Management (LKCM)
CMD

Luther King Capital Management (LKCM)’s Cantel Medical Corporation CMD Stock Holding History

Luther King Capital Management (LKCM)’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-42,325
Closed -$3.34M – 576
2020
Q4 		$3.34M Buy
42,325
+21,180
+100% +$1.24M 0.02% 221
2020
Q3 		$929K Sell
21,145
-5,290
-20% -$261K 0.01% 341
2020
Q2 		$1.17M Sell
26,435
-1,145
-4% -$42.7K 0.01% 307
2020
Q1 		$990K Buy
27,580
+720
+3% +$40.9K 0.01% 302
2019
Q4 		$1.9M Sell
26,860
-4,095
-13% -$297K 0.01% 290
2019
Q3 		$2.31M Buy
30,955
+13,135
+74% +$1.11M 0.02% 262
2019
Q2 		$1.44M Sell
17,820
-15,190
-46% -$1.07M 0.01% 303
2019
Q1 		$2.21M Sell
33,010
-13,795
-29% -$1.04M 0.02% 254
2018
Q4 		$3.48M Sell
46,805
-380
-0.8% -$31.4K 0.03% 197
2018
Q3 		$4.34M Sell
47,185
-2,135
-4% -$203K 0.03% 202
2018
Q2 		$4.85M Sell
49,320
-2,510
-5% -$281K 0.04% 185
2018
Q1 		$5.77M Sell
51,830
-6,365
-11% -$713K 0.05% 168
2017
Q4 		$5.99M Sell
58,195
-5,745
-9% -$572K 0.05% 178
2017
Q3 		$6.02M Sell
63,940
-1,300
-2% -$103K 0.05% 172
2017
Q2 		$5.08M Sell
65,240
-24,865
-28% -$1.87M 0.05% 187
2017
Q1 		$7.22M Sell
90,105
-35,640
-28% -$2.83M 0.07% 169
2016
Q4 		$9.9M Sell
125,745
-33,690
-21% -$2.62M 0.09% 153
2016
Q3 		$12.4M Sell
159,435
-44,710
-22% -$3.24M 0.12% 138
2016
Q2 		$14M Buy
204,145
+3,385
+2% +$233K 0.14% 141
2016
Q1 		$14.3M Buy
200,760
+77,300
+63% +$4.85M 0.14% 139
2015
Q4 		$7.67M Buy
123,460
+2,950
+2% +$180K 0.07% 209
2015
Q3 		$6.83M Buy
+120,510
New +$6.38M 0.07% 222

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Luther King Capital Management (LKCM)'s CMD Position: Q1 2021 in Review

Luther King Capital Management (LKCM) sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 42,325 shares — an estimated $3.34M sold.

Luther King Capital Management (LKCM) first reported a position in CMD in Q3 2015 and held it in 22 quarters. The position peaked at $14.3M in Q1 2016. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

  • Luther King Capital Management (LKCM) reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
  • Luther King Capital Management (LKCM) sold 42,325 Cantel Medical Corporation shares in Q1 2021, an estimated $3.34M.
  • Luther King Capital Management (LKCM) first reported a position in Cantel Medical Corporation in Q3 2015 and held it in 22 quarters.
  • Luther King Capital Management (LKCM)'s Cantel Medical Corporation position peaked at $14.3M in Q1 2016.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q1 2021, filed 12 May 2021.